Fifty years after the drug was launched in Britain, its victims are still fighting for compensation from its German makers Gary Skyner and Freddie Astbury had waited a long time for the meeting. The man they had arranged to see, Chris Matijasevic, was the managing director of the UK subsidiary of Grünenthal, a German company that is little known in this country to those outside the pharmaceutical industry.
Link to Article
0 comments:
Post a Comment